RxDoctor Payments Data

Kerri McGovern, MD

Medical Oncology · Cincinnati, OHNPI 1538587696

Payments from drug & device makers

$689in general payments, 2019–2025

Across 17 payments — averaging $40.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$432
  • Jazz Pharmaceuticals Inc.$62
  • Array Biopharma Inc$47
  • Daiichi Sankyo Inc.$26
  • Seagen Inc.$26
  • Gilead$24
  • plus $71 from 4 others

What the payments were for

  • Grants$35051%
  • Food & beverage$25337%
  • Education$8512%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$689 in reported general payments places this provider in the 15th percentile of 157 medical oncology providers in Ohio.

See all medical oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$28,357
Medicare patients
107
Services billed
231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Letrozole13$1,591
Anastrozole67$1,103
Prochlorperazine Maleate20$225
Dexamethasone16$153

Paid to pharmacies, not to this prescriber.

Other medical oncology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →